Arize: Arize brand male enhancement capsules — FDA announcement Feb 5, 2024

Published notice; closure not supplied

A company announcement posted by FDA. The listing date can differ from the original announcement date. The absence of a termination marker does not prove the recall is currently ongoing.

Source date Feb 5, 2024. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product
Arize brand male enhancement capsules
Reason
Products contain undeclared Nortadalafil
Classification
Not supplied
Recalling firm
Today the World
Quantity
Not supplied
Agency-reported status
Company recall announcement
Source record identifier
bfe39c48a018dc08

Open the official record

Lot and product identifiers

Label fieldDetails supplied by the agency
Lot, code or applicabilityFOR IMMEDIATE RELEASE – Feb 2, 2024 - VANCOUVER, WA, “Today The World” is voluntarily recalling one lot of Arize Herbal Dietary Supplement capsules to the consumer level. FDA analysis has found the products to contain undeclared Nortadalafil (structurally similar to Tadalafil). Nortadalafil is an active drug ingredient known for treatment of male erectile dysfunction. The presence of Nortadalafil in Arize makes this an unapproved new drug for which the safety and efficacy has not been established and, therefore subject to recall.; Today The World is notifying its customers of this recall via press release and is arranging for return/replacement etc. of all recalled product. Consumers that have Arize which is being recalled should stop using them. Product can be returned to Today The World, 11954 NE Glisan St # 405 Portland OR 97220 or destroyed. When returning Arize products, include the blister pack foil (with any remaining pills) containing the recalled lot number and receipt/proof of purchase, and your return address.

Match all identifying details in the current notice. A brand name alone is not enough.

Distribution

The product was distributed via website www.getarize.com in the USA. The product can be identified by –black box with the word Arize written in red on the front with a line underneath which reads: “For a rise that is hard to forget”.

No US distribution state could be established from this record. Check the official notice.

Dates in the source

Fda listing date
Feb 5, 2024
Company announcement date
Feb 2, 2024

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

Related records